(Q52055534)

20 April 2018

title

Relationship of psychotic symptoms to haloperidol-stimulated prolactin release. (English)

1 reference

20 April 2018

1 reference

Kulkarni J

1

1 reference

20 April 2018

Keks NA

2

1 reference

20 April 2018

Stuart G

3

1 reference

20 April 2018

Mackie B

4

1 reference

20 April 2018

Minas IH

5

1 reference

20 April 2018

Singh BS

6

1 reference

20 April 2018

Copolov DL

7

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 October 1990

1 reference

20 April 2018

Acta Psychiatrica Scandinavica

published in

1 reference

20 April 2018

volume

82

1 reference

20 April 2018

issue

4

1 reference

20 April 2018

page(s)

271-274

1 reference

20 April 2018

Negative v positive schizophrenia. Definition and validation.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1990.TB01383.X

The prolactin secretory response to neuroleptic drugs: Mechanisms, applications and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1990.TB01383.X

Variability of prolactin response to intravenous and intramuscular haloperidol in normal adult men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1990.TB01383.X

Abnormal prolactin response to haloperidol challenge in men with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1990.TB01383.X

The dopamine hypothesis of schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1990.TB01383.X

The two-syndrome concept: origins and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1990.TB01383.X

Schneider's first-rank symptoms of schizophrenia. An association with increased growth hormone response to apomorphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1990.TB01383.X

Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1990.TB01383.X

Serum prolactin levels in unmedicated schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1990.TB01383.X

The inhibition of the conditioned response and the counteraction of schizophrenia by muscarinic stimulation of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1990.TB01383.X

Effects of oxotremorine and physostigmine on the turnover of dopamine in the corpus striatum and the limbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1990.TB01383.X

10.1111/J.1600-0447.1990.TB01383.X

21 January 2018

Identifiers

DOI

1 reference

20 April 2018

1 reference

20 April 2018